Arcellx (ACLX) Long-Term Investments (2023 - 2025)
Arcellx's quarterly Long-Term Investments came in at $69.7 million in Q4 2025, up 82.14% year-on-year from $38.3 million in Q4 2024, and down 39.16% quarter-over-quarter from $114.6 million in Q3 2025.
Arcellx has reported Long-Term Investments for 3 years, with the latest figure at $69.7 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments rose 82.14% year-over-year to $69.7 million; the trailing twelve-month figure through Dec 2025 stood at $69.7 million (up 82.14% YoY), and the FY2025 full-year result was $69.7 million, up 82.14% from the prior year.
- Long-Term Investments for Q4 2025 stood at $69.7 million, down from $114.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $130.1 million in Q2 2024, with the low at $21.9 million in Q1 2025.
- Average Long-Term Investments over 3 years is $74.9 million, with a median of $77.1 million recorded in 2025.
- Year-over-year, Long-Term Investments jumped 138.43% in 2024 and plunged 81.26% in 2025.
- Tracing ACLX's Long-Term Investments over 3 years: stood at $27.2 million in 2023, then jumped by 40.89% to $38.3 million in 2024, then soared by 82.14% to $69.7 million in 2025.
- The last three Long-Term Investments figures came in at $69.7 million (Q4 2025), $114.6 million (Q3 2025), and $84.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 69.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.72 Mn |
| Sep 30, 2025 | 114.59 Mn |
| Jun 30, 2025 | 84.50 Mn |
| Mar 31, 2025 | 21.94 Mn |
| Dec 31, 2024 | 38.28 Mn |
| Sep 30, 2024 | 102.43 Mn |
| Jun 30, 2024 | 130.13 Mn |
| Mar 31, 2024 | 117.10 Mn |
| Dec 31, 2023 | 27.17 Mn |
| Sep 30, 2023 | 42.96 Mn |